Tubulin inhibitor 11

CAS No. 2366260-33-3

Tubulin inhibitor 11( —— )

Catalog No. M36093 CAS No. 2366260-33-3

Tubulin Inhibitor 11 is a potent, orally active agent that inhibits tubulin by targeting the Colchicine binding site. It impedes tubulin polymerization, leading to mitotic blockade and apoptosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 76 Get Quote
5MG 116 Get Quote
10MG 187 Get Quote
25MG 419 Get Quote
50MG 618 Get Quote
100MG 860 Get Quote
500MG 1728 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Tubulin inhibitor 11
  • Note
    Research use only, not for human use.
  • Brief Description
    Tubulin Inhibitor 11 is a potent, orally active agent that inhibits tubulin by targeting the Colchicine binding site. It impedes tubulin polymerization, leading to mitotic blockade and apoptosis.
  • Description
    Tubulin inhibitor 11 is a potent and orally active tubulin inhibitor. Tubulin inhibitor 11 targets the Colchicine binding site on tubulin, inhibits tubulin polymerization, promotes mitotic blockade and apoptosis.
  • In Vitro
    Tubulin inhibitor 11 (Compound 48; 0.03-0.1 μM; 12 hours) causes cell cycle arrest at G2/M phase. Tubulin inhibitor 11 reduces cdc2 phosphorylation and increases cyclin B1 and phosphorylation of histone H3 at Ser10 in cells.Tubulin inhibitor 11 (Compound 48; 0.03-0.3 μM; 48 hours) causes cancer cell apoptosis.Tubulin inhibitor 11 (Compound 48) demonstrates favorable antiproliferative activities in DU145 cells with an IC50 of 8 nM.Tubulin inhibitor 11 (Compound 48; 0.03-0.3 μM) significantly reduces the expression levels of acetyl-α-tubulin and α-tubulin in a dose-dependent manner.Cell Cycle Analysis Cell Line:DU145 cells Concentration:0.01 μM, 0.03 μM, and 0.1 μM Incubation Time:12 hours Result:Caused cell cycle arrest at G2/M phase.Apoptosis Analysis Cell Line:DU145 cells Concentration:0.03 μM, 0.1 μM, and 0.3 μM Incubation Time:48 hours Result: Induced cancer cell apoptosis.Western Blot Analysis Cell Line:DU145 cells Concentration:0.01 μM, 0.03 μM, and 0.1 μM Incubation Time:12 hours Result:Reduced cdc2 phosphorylation and increased cyclin B1 and phosphorylation of histone H3 at Ser10 in cells.
  • In Vivo
    Tubulin inhibitor 11 (Compound 48; 5-10 mg/kg; p.o; once daily) shows robust in vivo antitumor efficacies.Animal Model:Male athymic BALB/c nude mice (18-20 g) injected with DU145, NCI-H1299 or A549R cells Dosage:5 mg/kg, 10 mg/kg Administration:p.o; once dailyResult:Effectively suppressed tumor growth.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Microtubule Associated | Apoptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2366260-33-3
  • Formula Weight
    409.5
  • Molecular Formula
    C22H23N3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (244.20 mM; Ultrasonic )
  • SMILES
    N(S(=O)(=O)C1=CC=C(C)C=C1)C2=CC(C(NCC=3C=CC(C)=NC3)=O)=CC=C2C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Songwen Lin, et al. Optimization of Benzamide Derivatives as Potent and Orally Active Tubulin Inhibitors Targeting the Colchicine Binding Site. J Med Chem. 2022 Dec 22;65(24):16372-16391. ?
molnova catalog
related products
  • CGS8216

    CGS8216 is a benzodiazepine receptor antagonist that shows analgesic activity at high doses.CGS8216 has anxiolytic activity and may be used to study immune system disorders.

  • Clopipazan

    Clopipazan is an antipsychotic and antidepressant compound.Clopipazan has sedative and anxiolytic activity, possibly due to selective GABergic blockade of certain interneurons.

  • Exendin-3 4 (59-86)

    Exendin-3/4 (59-86) is a Exendin-4 peptide derivative.